Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
WEBINAR: Challenges in the management of fragile CAT patients (older patient population & palliative care) by ICTHIC Editorial Office 9 March 2023
Abstract submission deadline for ESMO Breast Cancer Congress by ICTHIC Editorial Office 15 February 2023
Abstract submission now open for ESMO 2023 by ICTHIC Editorial Office 15 February 2023
31th Congress of the International Society on Thrombosis and Haemostasis by ICTHIC Editorial Office 9 February 2023
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Thrombosis and cancer › Therapy

Therapy

Immune checkpoint inhibitors and cancer-associated thrombosis: an overview

Immune checkpoint inhibitors (ICIs) are a type of immunotherapy that revolutionized cancer treatment and, in recent...
Author ICTHIC Editorial OfficePosted on 15 March 202329 March 2023

Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients

Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
Author ICTHIC Editorial OfficeAuthor Anna FalangaPosted on 15 January 202314 February 2023

The Impact of DDI on the Cancer Patient

Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...
Author ICTHIC Editorial OfficePosted on 22 December 202222 December 2022

What do we know about bleeding risk in patients with cancer?

Venous thromboembolism (VTE) is a well-recognized complication in patients with cancer, with an increase in risk by a...
Author Cornelia EnglischPosted on 7 December 2022

DEBATE: Should VTE treatment continue beyond six months? The evidence behind the decision to continue anticoagulation

During the 11th ICTHIC, Agnes YY Lee and Marcello Di Nisio debated whether anticoagulation treatment should be...
Author ICTHIC Editorial OfficePosted on 21 August 202223 August 2022

DEBATE: Should VTE treatment continue beyond 6 months? Evidence supporting anticoagulation discontinuation

During the 11th ICTHIC, Agnes YY Lee and Marcello Di Nisio debated whether anticoagulation treatment should be...
Author ICTHIC Editorial OfficePosted on 10 August 202223 August 2022

Evolving data on cardiovascular complications in cancer

During the 11th ICTHIC, Hugo Ten Cate talked about the evolving data on cardiovascular complications in cancer. Here,...
Author ICTHIC Editorial OfficePosted on 26 July 202225 January 2023

Thrombosis management in hematological cancers vs solid tumors: what are the differences?

During the ICTHIC webinar “CAT management: challenges in different cancer populations,” Prof Darko Antic...
Author ICTHIC Editorial OfficePosted on 25 March 202227 March 2022

VTE risk in patients with ovarian cancer undergoing neoadjuvant chemotherapy.

Ovarian cancer is the ninth most common type of cancer and the seventh most common cause of cancer death in women . In...
Author ICTHIC Editorial OfficePosted on 25 January 202224 January 2022

Coagulation proteases, DOACs and their clinical impact on checkpoint inhibitor therapy

The hemostatic system in cancer The hemostatic system forms an integral part of the innate immune system and...
Author Wolfram RufAuthor Claudine GrafPosted on 30 November 2021

Posts navigation

Page 1 Page 2 Page 3 Next page

ICTHIC magazine is supported by the unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.